Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Deglutition × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Deglutition Disorders 2 Tongue Neoplasms 1 Speech Intelligibility 1 Mouth Neoplasms 1 Jaw Neoplasms 1 Head and Neck Neoplasms 1 Communication Disorders 1

Interventions

Cisplatin 256 Radiotherapy 193 Cetuximab 150 pembrolizumab 121 Docetaxel 95 Fluorouracil 92 Carboplatin 79 Paclitaxel 78 Radiotherapy, Intensity-Modulated 72 Surveys and Questionnaires 45 Nivolumab 42 Drug Therapy 34 Radiation 33 Blood Specimen Collection 26 Gemcitabine 25 Erlotinib Hydrochloride 25 Immunohistochemistry 22 Gefitinib 22 Surgical Procedures, Operative 21 Cyclophosphamide 21 durvalumab 19 Standard of Care 19 Pemetrexed 19 Magnetic Resonance Spectroscopy 19 Radiosurgery 17 Capecitabine 17 Chemotherapy, Adjuvant 16 Biopsy 16 atezolizumab 15 Low-Level Light Therapy 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05187091 2026-04-15

SWOAR

All India Institute of Medical Sciences

Phase 3 Active not recruiting

Deglutition Disorders, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡